Nephrogenic fibrosing dermopathy: Report of two cases

Acta Dermato-Venereologica

Volumn 87, Issue 6, 2007, Pages 521-524

  Aires, Nádia Barbosa ^a,b   Sotto, Mirian N ^a   Nico, Marcello M S ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

Kidney transplantation; Nephrogenic fibrosing dermopathy; Scleromyxoedema like cutaneous disease

Indexed keywords

AZATHIOPRINE; BLOOD CLOTTING FACTOR 13A; CD34 ANTIGEN; CYCLOSPORIN A; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ACUTE KIDNEY FAILURE; ADD ON THERAPY; ADULT; ANASARCA; ARTICLE; CASE REPORT; CHRONIC KIDNEY FAILURE; ERYTHEMA; FEMALE; GRAFT REJECTION; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; NEPHROGENIC FIBROSING DERMOPATHY; PERITONEAL DIALYSIS; PLASMAPHERESIS; PRIORITY JOURNAL; REMISSION; DENDRITIC CELL; FIBROSIS; IMMUNOHISTOCHEMISTRY; METABOLISM; PATHOLOGY; REVIEW; SKIN; SKIN DISEASE;

ADULT; ANTIGENS, CD34; DENDRITIC CELLS; FACTOR XIIIA; FEMALE; FIBROSIS; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY FAILURE, CHRONIC; SKIN; SKIN DISEASES;

EID: 38849126355     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-0296     Document Type: Article

References (28)

1. Gambichler T, Paech V, Kreuter A, Wilmert M, Altmeyer P, Stucker M. Nephrogenic fibrosing dermopathy. Clin Exp Dermatol 2004, 29: 258-260.
2. Cowper SE, Robin HS, Steinberg SM, Su LD, Gupta S, LeBoit PE. Scleromyxoedema-like cutaneous disease in renal-dialysis patients. Lancet 2000; 356: 1000-1001.
3. Swaminathan S, Leung N. Nephrogenic fibrosing dermopathy: lessons from the past. Int J Dermatol 2006; 45: 639-641.
4. Cowper SE, Bucala R, LeBoit PE. Case 35-2004: nephrogenic fibrosing dermopathy. N Engl J Med 2005; 352: 1723-1724.
5. Cowper SE. Nephrogenic fibrosing dermopathy [NFD/NSF Website]. 2001-2005. Available from: http://www.icnfdr.org. Accessed 07/04/2006.
6. Cowper SE. Nephrogenic fibrosing dermopathy: the first 6 years. Curr Opin Rheumatol 2003; 15: 785-790.
7. Streams BN, Liu V, Liegeois N, Moschella SM. Clinical and pathologic features of nephrogenic fibrosing dermopathy: a report of two cases. J Am Acad Dermatol 2003; 48: 42-47.
8. Evenepoel P, Zeegers M, Segaert S, Claes K, Kuypers D, Maes B, et al. Nephrogenic fibrosing dermopathy: a novel, disabling disorder in patients with renal failure. Nephrol Dial Transplant 2004; 19: 469-473.
9. Markus JS, James AJ, Nunez-Gussman JK, Sheehan AM, Fegan L, Hsu S. Nephrogenic fibrosing dermopathy. J Am Acad Dermatol 2005; 52: 166-167.
10. Jimenez SA, Artlett CM, Sandorfi N, Derk C, Latinis K, Sawaya H, et al. Dialysis-associated systemic fibrosis (nephrogenic fibrosing dermopathy) study of inflammatory cells and transforming growth factor β1 expression in affected skin. Arthrit Rheum 2004; 50: 2660-2666.
11. Ishibe S, Perazella MA, Reilly RF. Nephrogenic fibrosing dermopathy: an unusual skin condition associated with kidney disease. Semin Dialysis 2003; 16: 276-280.
12. Cowper SE. Nephrogenic systemic fibrosis: the nosological and conceptual evolution of nephrogenic fibrosing dermopathy. Am J Kidney Dis 2005; 46: 763-765.
13. Gilliet M, Cozzio A, Burg G, Nestle FO. Successful treatment of three cases of nephrogenic fibrosing dermopathy with extracorporeal photopheresis. Br J Dermatol 2005; 152: 531-536.
14. Mackay-Wiggan JM, Cohen DJ, Hardy MA, Knobler EH, Grossman ME. Nephrogenic fibrosing dermopathy (scleromyxedema-like illness of renal disease). J Am Acad Dermatol 2003; 48: 55-60.
15. Cowper SE, Su LD, Bhawan J, Robin HS, LeBoit PE. Nephrogenic fibrosing dermopathy. Am J Dermatopathol 2001; 23: 383-393.
16. Dawn G, Holmes SC. Scleromyxoedema-like eruption following haemodialysis or nephrogenic fibrosing dermopathy? Br J Dermatol 2004; 150: 155-177.
17. Neudecker BA, Stern R, Mark LA, Steinber S. Scleromyxoedema-like lesions of a patient in renal failure contain hyaluronan: a possible pathophysiological mechanism. J Cutan Pathol 2005; 32: 612-615.
18. Fazeli A, Lio PA, Liu V. Nephrogenic fibrosing dermopathy: are ACE inhibitors the missing link? Arch Dermatol 2004; 140: 1401.
19. Cowper SE, Bucala R. Nephrogenic fibrosing dermopathy: suspect identified, motive unclear. Am J Dermatopathol 2003; 25: 358.
20. Ting WW, Stone MS, Madison KC, Kurtz K. Nephrogenic fibrosing dermopathy with systemic involvement. Arch Dermatol 2003; 139: 903-906.
21. Taylor RS, Levine JM, Jimenez SA. Case 35-2004: Nephrogenic fibrosing dermopathy. N Engl J Med 2005; 352: 1723-1724.
22. Ortonne N, Lipsker D, Chantrel F, Boehm N, Grosshans E, Cribier B. Presence of CD45RO+CD34+ cells with collagen synthesis activity in nephrogenic fibrosing dermopathy: a new pathogenic hypothesis. Br J Dermatol 2004; 150: 1028-1054.
23. Baron PW, Cantos K, Hillebrand DJ, Hu KQ, Ojogho ON, Nehlsen-Cannarella S, Concepcion W. Nephrogenic fibrosing dermopathy after liver transplantation successfully treated with plasmapheresis. Am J Dermatopathol 2003; 25: 204-209.
24. Chung HJ, Chung KY. Nephrogenic fibrosing dermopathy: response to high dose intravenous immunoglobulin. Br J Dermatol 2004; 150: 596-624.
25. LeBoit PE. What nephrogenic fibrosing dermopathy might be. Arch Dermatol 2003; 139: 928-930.
26. Kafi R, Fisher GJ, Quan T, Shao Y, Wang R, Voorhees JJ, Kang S. UV-A1 phototherapy improves nephrogenic fibrosing dermopathy. Arch Dermatol 2004, 140: 1322-1324.
27. Schmook T, Budde K, Ulrich C, Neumayer HH, Fritsche L, Stockfleth E. Successful treatment of nephrogenic fibrosing dermopathy in a kidney transplant recipient with photodynamic therapy. Nephrol Dial Transplant 2005; 20: 220-222.
28. Rose R, Lyon C. The successful treatment of nephrogenic fibrosing dermopathy with mycophenolate mofetil. J Am Acad Dermatol 2005; 52: 62.